Case number 2020-1186
Arbutus Biopharma Corporation v. Moderna Therapeutics, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 25, 2022 | 11 | Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [826756] [20-1184, 20-1186] [MVH] [Entered: 01/25/2022 11:53 AM] (2) |
| Dec 1, 2021 | 9 | OPINION filed for the court by Lourie, Circuit Judge; O'Malley, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. Service as of this date by the Clerk of Court. [815496] [20-1184, 20-1186] [MJL] [Entered: 12/01/2021 09:04 AM] (19) |
| Dec 1, 2021 | 10 | JUDGMENT. DISMISSED-IN-PART, AFFIRMED-IN-PART. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [815497] [20-1184, 20-1186] [MJL] [Entered: 12/01/2021 09:05 AM] (2) |
| Jun 25, 2021 | 8 | ORDER granting motion to modify the official caption [781000-2] filed by Cross-Appellant Protiva Biotherapeutics, Inc. in 20-1184. The revised official caption and short caption are reflected in the order. Service as of this date by the Clerk of Court. [782650] [20-1184, 20-1186] [NL] [Entered: 06/25/2021 10:58 AM] (2) |
| Dec 12, 2019 | 7 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [3], attorney entry of appearance Docket No. [4], certificate of interest Docket No. [5], docketing statement Docket No. [6], ERROR: Moderna Therapeutics, Inc.'s filings were submitted in a cross-appeal to lead appeal 20-1184. CORRECTION: No action will be taken on these documents as compliant versions were also submitted in the lead appeal. All future filings must be submitted in 20-1184 only. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [655957] [TAM] [Entered: 12/12/2019 11:08 AM] (0) |
| Dec 11, 2019 | 3 | Entry of appearance for Michael R. Fleming as principal counsel for Appellee Moderna Therapeutics, Inc.. Service: 12/11/2019 by email. [655839] [20-1186] [Michael Fleming] [Entered: 12/11/2019 09:14 PM] (0) |
| Dec 11, 2019 | 4 | Entry of appearance for C. Maclain Wells as of counsel for Appellee Moderna Therapeutics, Inc.. Service: 12/11/2019 by email. [655840] [20-1186] [Michael Fleming] [Entered: 12/11/2019 09:15 PM] (0) |
| Dec 11, 2019 | 5 | Certificate of Interest for Appellee Moderna Therapeutics, Inc.. Service: 12/11/2019 by email. [655841] [20-1186] [Michael Fleming] [Entered: 12/11/2019 09:16 PM] (0) |
| Dec 11, 2019 | 6 | Docketing Statement for the Appellee Moderna Therapeutics, Inc.. Service: 12/11/2019 by email. [655842] [20-1186] [Michael Fleming] [Entered: 12/11/2019 09:17 PM] (0) |
| Nov 27, 2019 | 1 | Appeal docketed. Received: 11/13/2019. [652773] . [TAM] [Entered: 11/27/2019 11:37 AM] (0) |
| Nov 27, 2019 | 2 | Note to file: The following cases are associated:20-1184 (Lead) with 20-1186 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [652776] [20-1184, 20-1186] [TAM] [Entered: 11/27/2019 11:42 AM] (0) |
